The CAIRP (CAndesartan for In-stent Restenosis Prevention) Trial--a multicenter study of AT1-receptor blocker therapy in coronary stenting. [electronic resource]
Producer: 20080715Description: 205-10 p. digitalISSN:- 1557-2501
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Benzimidazoles -- therapeutic use
- Biphenyl Compounds
- Blood Vessel Prosthesis Implantation
- Combined Modality Therapy
- Coronary Angiography
- Coronary Restenosis -- drug therapy
- Double-Blind Method
- Drug-Eluting Stents
- Female
- Humans
- Male
- Middle Aged
- Placebos
- Prospective Studies
- Tetrazoles -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.